Select Medical Holdings Corporation

DB:S24 Stock Report

Market Cap: €2.3b

Select Medical Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

David Chernow

Chief executive officer

US$10.7m

Total compensation

CEO salary percentage9.3%
CEO tenure11yrs
CEO ownership0.7%
Management average tenure1.3yrs
Board average tenure14.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Chernow's remuneration changed compared to Select Medical Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$266m

Jun 30 2024n/an/a

US$259m

Mar 31 2024n/an/a

US$260m

Dec 31 2023US$11mUS$995k

US$235m

Sep 30 2023n/an/a

US$217m

Jun 30 2023n/an/a

US$196m

Mar 31 2023n/an/a

US$174m

Dec 31 2022US$9mUS$995k

US$153m

Sep 30 2022n/an/a

US$175m

Jun 30 2022n/an/a

US$223m

Mar 31 2022n/an/a

US$329m

Dec 31 2021US$12mUS$995k

US$389m

Sep 30 2021n/an/a

US$415m

Jun 30 2021n/an/a

US$415m

Mar 31 2021n/an/a

US$306m

Dec 31 2020US$8mUS$995k

US$250m

Sep 30 2020n/an/a

US$206m

Jun 30 2020n/an/a

US$162m

Mar 31 2020n/an/a

US$155m

Dec 31 2019US$8mUS$995k

US$143m

Sep 30 2019n/an/a

US$136m

Jun 30 2019n/an/a

US$138m

Mar 31 2019n/an/a

US$140m

Dec 31 2018US$8mUS$995k

US$133m

Compensation vs Market: David's total compensation ($USD10.71M) is above average for companies of similar size in the German market ($USD1.57M).

Compensation vs Earnings: David's compensation has increased by more than 20% in the past year.


CEO

David Chernow (67 yo)

11yrs

Tenure

US$10,706,265

Compensation

Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...


Leadership Team

NamePositionTenureCompensationOwnership
Robert Ortenzio
Co-Founder & Executive Chairman19.9yrsUS$10.77m6.94%
€ 159.8m
David Chernow
Chief Executive Officer11yrsUS$10.71m0.73%
€ 16.8m
Michael Malatesta
Executive VP & CFO1.3yrsUS$1.53m0.13%
€ 3.0m
Michael Tarvin
Senior Executive VP27.9yrsUS$4.44m0.34%
€ 7.8m
Martin Jackson
Senior Executive Vice President of Strategic Finance & Operations1.3yrsUS$6.47m0.99%
€ 22.7m
John Saich
Co-President1.3yrsno data0.51%
€ 11.8m
Thomas Mullin
Co-President1.3yrsno data0.24%
€ 5.6m
Christopher Weigl
Senior VP1.8yrsno data0.027%
€ 611.5k
Brian Rusignuolo
Executive VP & Chief Information Officer4yrsno data0.23%
€ 5.4m
Robert Breighner
Senior Vice President of Compliance & Auditno datano data0.024%
€ 541.9k
Shelly Eckenroth
Senior VP & Chief Communications1.3yrsno datano data
Mary Lacey
Senior VP & Chief Human Resources Officer1.3yrsno datano data

1.3yrs

Average Tenure

55yo

Average Age

Experienced Management: S24's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Robert Ortenzio
Co-Founder & Executive Chairman19.9yrsUS$10.77m6.94%
€ 159.8m
Russell Carson
Independent Lead Director19.9yrsUS$384.40k0.85%
€ 19.6m
Thomas Scully
Independent Director20.9yrsUS$383.40k0.069%
€ 1.6m
Daniel Thomas
Independent Director5.5yrsUS$405.80k0.051%
€ 1.2m
William Frist
Independent Director14.7yrsUS$407.83k0.22%
€ 5.1m
Marilyn Tavenner
Independent Director6.2yrsUS$394.40k0.017%
€ 392.9k
James Ely
Independent Director16.2yrsUS$414.83k0.11%
€ 2.6m
Katherine Davisson
Independent Director3.8yrsUS$409.80k0.036%
€ 821.3k
Parvinderjit Khanuja
Independent Director3.2yrsUS$407.83k0.034%
€ 787.2k

14.7yrs

Average Tenure

66yo

Average Age

Experienced Board: S24's board of directors are seasoned and experienced ( 14.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 09:05
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Select Medical Holdings Corporation is covered by 18 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian WilliamsAvondale Partners
Benjamin MayoBaird
William SutherlandBenchmark Company